Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report)’s share price was down 0.6% during trading on Monday . The stock traded as low as $64.70 and last traded at $64.70. Approximately 1 shares traded hands during mid-day trading, The stock had previously closed at $65.10.
Basilea Pharmaceutica Trading Down 0.6%
The company has a current ratio of 5.11, a quick ratio of 4.68 and a debt-to-equity ratio of 0.59. The business has a fifty day moving average price of $61.43 and a two-hundred day moving average price of $67.04.
About Basilea Pharmaceutica
Basilea Pharmaceutica AG is a Swiss biopharmaceutical company headquartered in Basel, specializing in the development and commercialization of innovative treatments for hospital‐treated diseases. The company’s research is focused primarily on anti‐infectives and oncology, with a portfolio that spans both marketed products and early‐ to late‐stage pipeline candidates. Basilea leverages medicinal chemistry expertise to address critical medical needs in fungal infections, bacterial infections and cancer.
Among its lead products is isavuconazole, a broad‐spectrum antifungal agent marketed under the trade name Cresemba.
Further Reading
- Five stocks we like better than Basilea Pharmaceutica
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
